logo
XenDex Extends $XDX Presale as Exchange Listing Discussions Progress with Leading Exchanges

XenDex Extends $XDX Presale as Exchange Listing Discussions Progress with Leading Exchanges

Business Upturn5 days ago

By GlobeNewswire Published on May 30, 2025, 02:09 IST
SYDNEY, May 29, 2025 (GLOBE NEWSWIRE) — XenDex has confirmed it is actively negotiating with several top-tier exchanges ahead of the official listing of its native token, $XDX. This revelation comes just as the project team announced a limited extension of its presale phase due to overwhelming demand and investor requests.
With over 93% of the $XDX presale allocation already sold, this final window which is just about 72-hour grace period, is the last chance for late investors to buy the token at discounted presale rates and $XDX will launch at market price across multiple exchanges.
The presale extension coincides with bullish developments within the broader XRP ecosystem. Ripple has announced its acquisition of Circle, the issuer of USDC, while Volatility Shares has launched the XRPI Futures ETF, both of which have sent positive shockwaves across the crypto market. As institutional interest in XRP surges, XenDex is riding that momentum as the most anticipated DeFi platform to emerge on XRPL.
What Makes XenDex Unique?
Buy $XDX At Discount Price
XenDex merges multiple financial tools into a single interface: AI Copy Trading : Automatically mimic the trades of top-performing traders and minimize loss.
: Automatically mimic the trades of top-performing traders and minimize loss. Lending & Borrowing : Lend or borrow assets directly without third-party interference.
: Lend or borrow assets directly without third-party interference. Cross-Chain Swaps : Trade XRP assets across other blockchains like; Ethereum, BNB, Solana, and more.
: Trade XRP assets across other blockchains like; Ethereum, BNB, Solana, and more. DAO Governance: $XDX holders can vote on major protocol upgrades and decisions.
Why Buy $XDX Now?
Aside from pumping upon listing, and trading on exchanges, early holders of $XDX gain access to: Staking and yield farming rewards
Reduced fees on all trading, lending, borrowing and other DeFi functions
Priority access to new features, listings, and platform upgrades
Governance voting rights that give users control over the platform's future upgrades and decisions
XenDex Presale
Crypto analysts are already speculating a strong pump once $XDX gets listed on the exchanges. After the presale, $XDX is expected to be available for trading on major exchanges, with active discussions currently underway with Binance, Gate.io, MEXC, BitMart, MagneticX, and FirstLedger.
How To Buy $XDX During The Presale? Visit the official presale link: https://xendex.net/presale Set up a Trustline using an XRP-compatible wallet (e.g., Xaman) Minimum buy is 150 XRP Exchange rate is 1.25 XRP = 10 XDX Full guide available here: https://xdxdocs.gitbook.io/xendex/buy-usdxdx-token-presale
XenDex Presale Details Soft Cap: Reached
Hard Cap: 93% SoldTime Left: 72-Hour Grace Period Only
Presale Rate: 150 XRP = 1200 $XDX
Buy XDX At A Cheap Rate: https://xendex.net/presale
Join XenDex Community Below
Website: https://xendex.net
Presale: https://xendex.net/presale
Telegram: https://t.me/xendexcommunity
Twitter/X: https://x.com/xendex_xrp
Docs: https://xdxdocs.gitbook.io
Contact:Frank Richards
[email protected]
Disclaimer : This is a paid post provided by XenDex. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. We do not guarantee any claims, statements, or promises made in this article. This content is for informational purposes only and should not be considered financial, investment, or trading advice.
Investing in crypto and mining-related opportunities involves significant risks, including the potential loss of capital. It is possible to lose all your capital. These products may not be suitable for everyone, and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. However, due to the inherently speculative nature of the blockchain sector—including cryptocurrency, NFTs, and mining—complete accuracy cannot always be guaranteed. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility. Globenewswire does not endorse any content on this page.
Legal Disclaimer: This media platform provides the content of this article on an 'as-is' basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/21f5b11e-8e3c-4c85-ade4-c35c34332d19
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How Glassnode's data revolution empowers wealthy investors
How Glassnode's data revolution empowers wealthy investors

Yahoo

time36 minutes ago

  • Yahoo

How Glassnode's data revolution empowers wealthy investors

How Glassnode's data revolution empowers wealthy investors originally appeared on TheStreet. Are you leaving millions on the table in the crypto market? For high net-worth individuals and family offices, the digital asset space can feel like a gamble—complex, risky, and opaque. Enter Glassnode, the leading blockchain data and intelligence platform trusted by top hedge funds, banks, and traders worldwide. With cutting-edge on-chain analytics, Glassnode turns the crypto market from a black-and-white snapshot into a vivid, 3D masterpiece, revealing opportunities and risks others miss. Daniel Blackmore, Glassnode's Chief Commercial Officer, explains how their data-driven insights are helping traditional investors conquer crypto with confidence—and rake in alpha. Daniel Blackmore's journey to Glassnode started in the high-stakes world of traditional finance. 'I spent most of my career in banking as an interest rates trader and salesperson, dealing with hedge funds, sovereign wealth funds, and banks,' Blackmore shared. Frustrated by manual processes that screamed for automation, he saw blockchain and smart contracts as the solution. This led him to Coinbase Institutional, where he worked with financial giants, before joining Glassnode to tackle a bigger challenge: making crypto markets transparent and actionable. 'Glassnode is helping trading institutions, investors, and researchers form a view on digital assets and act upon it,' Blackmore explained. The problem? Most investors rely on outdated, traditional datasets—spot prices, ETFs, futures—that leave them blind to crypto's unique dynamics. Glassnode's on-chain data reveals what's really happening under the hood, from capital flows to investor behavior, giving users an edge in a market where billions have been lost to poor decisions. For high net-worth individuals, crypto can seem like a leap into the unknown. Blackmore gets it. 'They're using traditional approaches, which do fine, but they're leaving money on the table,' he said. Conventional data like market prices or ETF flows shows only half the picture—it's like trading in 2D. 'When you add on-chain data, it's like seeing things in color or in 3D,' Blackmore emphasized. Imagine tracking money moving from wallet to wallet, identifying whether it's a hedge fund or a retail trader, a long-term holder or a short-term speculator. Glassnode's analytics—covering Bitcoin, Ethereum, DeFi, and more—let you see capital flows, investor psychology, and market sentiment in real time. For example, their recent Q4 2024 report with Fasanara Digital highlighted Bitcoin's surge to $90K and ETF inflows, pinpointing where smart money is moving. This isn't guesswork—it's data-driven alpha that helps you outsmart the market. What's holding TradFi investors back? 'The biggest thing crypto-native people forget is how deep in the weeds they are,' Blackmore noted. Complex jargon and tech details scare off newcomers who just want the basics: how to buy, store, and profit safely. 'They need Bitcoin 101—how to buy assets, store them, or have a custodian do it,' he said. Many prefer custodians over self-custody, and Glassnode bridges this gap by speaking TradFi's language, using familiar frameworks enhanced with on-chain insights. Think of crypto like cloud computing in the early 2000s. 'People don't need to know how the cloud works—they just know it's superior,' Blackmore said. Glassnode simplifies blockchain data so you don't need a PhD to take advantage of opportunities. Their tools ensure security and clarity, letting you focus on returns, not risks. With over 800,000 users and partnerships with giants like Coinbase Institutional and CME Group, Glassnode's credibility is rock-solid. What sets Glassnode apart? Their comprehensive analytics suite combines on-chain and off-chain data, offering metrics like Supply Mapping and Cost Basis Distribution to reveal investor behavior across hundreds of assets. 'We're engaging with tier-1 players—hedge funds, proprietary trading firms, VCs, family offices, banks,' Blackmore said. Their 'Week On-Chain' and 'Market Pulse' reports deliver quick, actionable insights, while bespoke research helps institutions tailor strategies. Recent posts on X highlighted Bitcoin's rally and profit-taking trends, showing how Glassnode spots market shifts others miss. Unlike competitors like Chainalysis or Nansen, Glassnode's focus on institutional-grade tools and deep coverage of Bitcoin, Ethereum, and 500+ ERC-20 tokens makes it the go-to for serious investors. How Glassnode's data revolution empowers wealthy investors first appeared on TheStreet on Jun 3, 2025 This story was originally reported by TheStreet on Jun 3, 2025, where it first appeared.

Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference
Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference

Yahoo

timean hour ago

  • Yahoo

Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference

NOVATO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil Kakkis, M.D., Ph.D., the company's chief executive officer, will participate in a fireside at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025, at 10:00 a.m. ET. The live and archived webcast of the panel will be accessible from the company's website at About Ultragenyx Pharmaceutical Inc. Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx's strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency. For more information on Ultragenyx, please visit the company's website at: Contacts – Ultragenyx Pharmaceutical, Higa ir@

Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference
Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference

Yahoo

time2 hours ago

  • Yahoo

Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference

NOVATO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil Kakkis, M.D., Ph.D., the company's chief executive officer, will participate in a fireside at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025, at 10:00 a.m. ET. The live and archived webcast of the panel will be accessible from the company's website at About Ultragenyx Pharmaceutical Inc. Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx's strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency. For more information on Ultragenyx, please visit the company's website at: Contacts – Ultragenyx Pharmaceutical, Higa ir@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store